Sari I, Birlik M, Kasifoglu T. Familial Mediterranean fever: an updated review. Eur J Rheumatol. 2014;1(1):21–3. https://doi.org/10.5152/eurjrheum.2014.006.
Article
PubMed
PubMed Central
Google Scholar
Ozen S, Bilginer Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nat Rev Rheumatol. 2014;10(3):135–47. https://doi.org/10.1038/nrrheum.2013.174.
Article
CAS
PubMed
Google Scholar
Nursal AF, Tekcan A, Kaya SU, Turkmen E, Yigit S. Mutational Spectrum of the MEFV Gene in AA Amyloidosis Associated With Familia Mediterranean Fever. IJKD. 2016;10:107–12.
PubMed
Google Scholar
Ozen S. Update on the epidemiology and disease outcome of Familial Mediterranean fever. Best Pract Res Clin Rheumatol. 2018;32:254e260.
Google Scholar
International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797–807.
Article
Google Scholar
Ozen S, Batu ED, Demir S. Familial Mediterranean fever: recent developments in pathogenesis and new recommendations for management. Front Immunol. 2017;8:253. https://doi.org/10.3389/fimmu.2017.00253 eCollection.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ben-Zvi I, Herskovizh C, Kukuy O, Kassel Y, Grossman C, Livneh A. Familial Mediterranean fever without MEFV mutations: a case-control study. Orphanet J Rare Dis. 2015;10:34.
Article
Google Scholar
Campbell L, Raheem I, Malemud CJ, Askari AD. The relationship between NALP3 and autoinflammatory syndromes. Int J Mol Sci. 2016;17(5):725. https://doi.org/10.3390/ijms17050725.
Article
CAS
PubMed Central
Google Scholar
Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, et al. Gain of function pyrin mutations induce NLRP3 protein –independent interleukin-1 beta activation and severe autoinflammation in mice. Immunity. 2011;34(5):755–68. https://doi.org/10.1016/j.immuni.2011.02.020.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sönmez HE, Batu ED, Özen S. Familial Mediterranean fever: current perspectives. J Inflamm Res. 2016;9:13–20. https://doi.org/10.2147/JIR.S91352.
Article
PubMed
PubMed Central
Google Scholar
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40(10):1879–85. https://doi.org/10.1002/art.1780401023.
Article
CAS
PubMed
Google Scholar
Yalcinkaya F, Ozen S, Ozcakar ZB, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology. 2009;48(4):395–8. https://doi.org/10.1093/rheumatology/ken509.
Article
PubMed
Google Scholar
Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016;75(4):644–51. https://doi.org/10.1136/annrheumdis-2015-208690.
Article
CAS
PubMed
Google Scholar
Gül A, Ozdogan H, Erer B, et a (2015) Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever. Arthritis Res Ther 17:243, 1, DOI: https://doi.org/10.1186/s13075-015-0765-4.
Ozen S, Bilginer Y, Aktay Ayaz N, Calguneri M. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine. J Rheumatol. 2011;38(3):516–8. https://doi.org/10.3899/jrheum.100718.
Article
PubMed
Google Scholar
Ozen S, Kone-Paut I, Gül A. Colchicine resistance and intolerance in familial mediterranean fever: definition, causes, and alternative treatments. Semin Arthritis Rheum. 2017;47(1):115–20. https://doi.org/10.1016/j.semarthrit.2017.03.006.
Article
CAS
PubMed
Google Scholar
Ilaris (canakinumab) Prescribing Information. Novartis Pharmaceuticals Corporation. 2016.
Google Scholar
Ergul AB, Dursun I, Torun YA. Hashimoto’s thyroiditis in a child with familial mediterranean fever: a case report. Iran J Pediatr. 2013;23:489e90.
Google Scholar
Erten S, Taskaldiran I, Yakut ZI. Are systemic lupus erythematosus patients carrying MEFV gene less prone to renal involvement? Report of three cases and review of the literature. Ren Fail. 2013;35:1013e6.
Article
Google Scholar
Atabek ME, Pirgon O, Sert A, Arslan U. Familial Mediterranean fever associated with type 1 diabetes. Endocrinol. 2006;16:133e5.
Article
Google Scholar
Bas F, Kabatas-Eryılmaz S, Günöz H, Darendeliler F, Küçükemre B, Bundak R, et al. Type 1 diabetes mellitus associated with autoimmune thyroid disease, celiac disease and familial Mediterranean fever: case report. Turk J Pediatr. 2009;51:183e6.
Google Scholar
Topaloglu R, Batu ED, Yıldız Ç, Korkmaz E, Özen S, Beşbaş N, et al. Familial Mediterranean fever patients homozygous for E148Q variant may have milder disease. Int J Rheum Dis. 2018;21(10):1857–62. https://doi.org/10.1111/1756-185X.12929.
Article
CAS
PubMed
Google Scholar
Aydın F, Çakar N, Özçakar ZB, Uncu N, Başaran O, Özdel S. Clinical features and disease severity of Turkish FMF children carrying E148Q mutation. J Clin Lab Anal. 2019;33(4):e22852. https://doi.org/10.1002/jcla.22852.
Article
CAS
PubMed
PubMed Central
Google Scholar
Eroglu E, Kocyigit I, Ates O, Unal A, Sipahioglu MH, Akgun H, et al. Mesangial proliferative glomerulonephritis in familial Mediterranean fever patient with E148Q mutation: the first case report. Int Urol Nephrol. 2013;45(2):591–4. https://doi.org/10.1007/s11255-012-0124-1.
Article
PubMed
Google Scholar
Ardalan M, Nasri H. Massive proteinuria and acute glomerulonephritis picture in a patient with Familial Mediterranean fever and E148Q mutation. Iran J Kidney Dis. 2014;8(6):486–8.
PubMed
Google Scholar
Chandragiri S, Raju SB, Mandarapu SB, Goli R, Nimmagadda S, Uppin M. A Clinicopathological study of 267 patients with diabetic kidney disease based on the Renal Pathology Society - 2010 classification system. Indian J Nephrol. 2020;30(2):104–9.
Article
Google Scholar
DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391:2449–62. https://doi.org/10.1016/S0140-6736(18)31320-5.
Article
PubMed
PubMed Central
Google Scholar
Diplomatico M, Gicchino MF, Ametrano O, Marzuillo P, Olivieri AN. A case of urticarial vasculitis in a female patient with lupus: mycoplasma pneumoniae infection or lupus reactivation? Rheumatol Int. 2017;37(5):837–40. https://doi.org/10.1007/s00296-016-3626-9.
Article
PubMed
Google Scholar
Olivieri AN, Iafusco D, Mellos A, Zanfardino A, Mauro A, Granato C, et al. Refractory rheumatoid factor positive polyarthritis in a female adolescent already suffering from type 1 diabetes mellitus and Hashimoto's thyroiditis successfully treated with etanercept. Ital J Pediatr. 2013;39:64.
Article
Google Scholar
Kumar P, Subramaniyam G. Molecular underpinnings of Th17 immune-regulation and their implications in autoimmune diabetes. Cytokine. 2015;71(2):366–76. https://doi.org/10.1016/j.cyto.2014.10.010.
Article
CAS
PubMed
Google Scholar
Dogan Y, Akarsu S, Ustundag B, Yilmaz E, Gurgoze MK. Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children. Mediat Inflamm. 2006;2006(1):59206. https://doi.org/10.1155/MI/2006/59206.
Article
CAS
Google Scholar
Bradshaw EM, Raddassi K, Elyaman W, Orban T, Gottlieb PA, Kent SC, et al. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J Immunol. 2009;183(7):4432–9. https://doi.org/10.4049/jimmunol.0900576.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hu C, Ding H, Li Y, Pearson JA, Zhang X, Flavell RA, et al. NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets. Proc Natl Acad Sci U S A. 2015;112(36):11318–23. https://doi.org/10.1073/pnas.1513509112.
Article
CAS
PubMed
PubMed Central
Google Scholar